Today: 29 April 2026
ASML stock slips into the weekend — here’s what could move the chip-equipment bellwether next
1 February 2026
1 min read

ASML stock slips into the weekend — here’s what could move the chip-equipment bellwether next

New York, Feb 1, 2026, 10:39 (EST) — Market closed.

  • ASML’s U.S.-listed shares finished Friday roughly 2.2% lower, capping off a volatile week.
  • Attention is moving away from record orders toward delivery capacity, China exposure, and risk appetite shaped by rates.
  • Traders are focused on key macro data this week, alongside ASML’s upcoming dividend schedule.

ASML Holding NV shares dropped on Friday, ending the day at $1,423—a 2.2% decline—before edging up a bit in after-hours trading.

Markets are closed for the weekend, so all eyes turn to Monday’s open. The key question: will investors continue piling into chip-equipment stocks, or start dialing back risk after a sharp rally in January?

ASML occupies a crucial position. The company provides the advanced equipment chipmakers rely on to boost production, making its order book and guidance key indicators for the industry — particularly as investors gauge the duration of AI-fueled demand.

Earlier this week, the company projected 2026 sales between 34 billion and 39 billion euros, with its backlog at the end of 2025 around 38.8 billion euros. (Net bookings refer to new orders; backlog means orders still awaiting shipment.) CEO Christophe Fouquet described 2026 as “another growth year.” ASML

The optimistic outlook came with a familiar question: can ASML ramp up production quickly enough? On the company’s call, Fouquet dismissed worries about a “bottleneck,” even as analysts probed capacity and supply chain issues. Marc Hesselink of ING described the final quarterly orders report as “going out with a bang,” noting ASML’s plan to stop releasing quarterly order figures. Reuters

China continues to be a key variable. ASML’s management warned that China’s portion of sales will likely decline in 2026, due to export controls curbing shipments of its highest-end equipment, according to the same report.

Macro data could take center stage this week, stepping in where company news leaves off. Look for the euro zone’s flash inflation estimate on Feb. 4 and the U.S. January Employment Situation report on Feb. 6 — both have the power to sway bond yields. That often puts pressure on richly valued tech and semiconductor stocks.

Traders in the equipment sector will be eyeing any new hints from chipmakers about their capital spending. That’s the key factor that converts ASML’s backlog into actual revenue, and it also influences how suppliers throughout the supply chain move together in the market.

But the setup works both ways. Orders can come in fits and starts, delivery timelines may shift, and tighter export rules can alter the types of systems shipped and serviced, even if demand appears robust.

ASML’s dividend schedule is in focus next. The interim dividend will go ex-dividend on Feb. 9 on Euronext Amsterdam and Feb. 10 on Nasdaq. Payment is set for Feb. 18, per the company’s dividend timetable.

Stock Market Today

  • Biotech with $277M Cash Says It Can Fund Operations Through 2028
    April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 2:55 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
SK hynix stock price: Korea export surge sets up Monday test for chip shares
Previous Story

SK hynix stock price: Korea export surge sets up Monday test for chip shares

Cisco stock price: CSCO heads into AI Summit week as rate jitters hit tech
Next Story

Cisco stock price: CSCO heads into AI Summit week as rate jitters hit tech

Go toTop